These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15610934

  • 1. Nicotine treatment of obsessive-compulsive disorder.
    Lundberg S, Carlsson A, Norfeldt P, Carlsson ML.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1195-9. PubMed ID: 15610934
    [Abstract] [Full Text] [Related]

  • 2. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients.
    Salín-Pascual RJ, Basañez-Villa E.
    Rev Invest Clin; 2003 Nov; 55(6):650-4. PubMed ID: 15011734
    [Abstract] [Full Text] [Related]

  • 3. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM, Tarlow G, Bystritsky A.
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report.
    Pasquini M, Garavini A, Biondi M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):157-9. PubMed ID: 15610960
    [Abstract] [Full Text] [Related]

  • 7. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD, Kerwin L, Saxena S, Bystritsky A.
    Psychopharmacol Bull; 2009 Jan; 42(1):81-93. PubMed ID: 19204653
    [Abstract] [Full Text] [Related]

  • 8. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L, Topuz A.
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG, Bouhassira M, Lancrenon S.
    Encephale; 2000 Oct; 26(6):73-83. PubMed ID: 11217541
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Empathy and symptoms dimensions of patients with obsessive-compulsive disorder.
    Fontenelle LF, Soares ID, Miele F, Borges MC, Prazeres AM, Rangé BP, Moll J.
    J Psychiatr Res; 2009 Jan; 43(4):455-63. PubMed ID: 18614180
    [Abstract] [Full Text] [Related]

  • 14. Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder.
    Dougherty DD, Jameson M, Deckersbach T, Loh R, Thompson-Hollands J, Jenike M, Keuthen NJ.
    Int Clin Psychopharmacol; 2009 Nov; 24(6):306-11. PubMed ID: 19730388
    [Abstract] [Full Text] [Related]

  • 15. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.
    Stewart SE, Yen CH, Stack DE, Jenike MA.
    J Psychiatr Res; 2006 Sep; 40(6):511-9. PubMed ID: 16229857
    [Abstract] [Full Text] [Related]

  • 16. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, Katsovich L, Scahill L, King RA, Woody SR, Tolin D, Hollander E, Kano Y, Leckman JF.
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [Abstract] [Full Text] [Related]

  • 17. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N, Tan LW, Wang Q, Li ZX, Li LJ.
    Psychiatry Res; 2007 Feb 28; 150(1):61-9. PubMed ID: 17291595
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Symptom overlap between autism spectrum disorder, generalized social anxiety disorder and obsessive-compulsive disorder in adults: a preliminary case-controlled study.
    Cath DC, Ran N, Smit JH, van Balkom AJ, Comijs HC.
    Psychopathology; 2008 Feb 28; 41(2):101-10. PubMed ID: 18033980
    [Abstract] [Full Text] [Related]

  • 20. Obsessive-compulsive and eating disorders: comparison of clinical and personality features.
    Jiménez-Murcia S, Fernández-Aranda F, Raich RM, Alonso P, Krug I, Jaurrieta N, Alvarez-Moya E, Labad J, Menchón JM, Vallejo J.
    Psychiatry Clin Neurosci; 2007 Aug 28; 61(4):385-91. PubMed ID: 17610663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.